U.S., Feb. 11 -- An application to own the trademark for 'KYGEVVI' has been filed on Aug. 27, 2025.
Owner(s):
UCB Biosciences Inc.; 4000 Paramount Parkway, Suite 200, NORTH CAROLINA
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of tk2 gene diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) IN
https://eog-tmng.uspto.gov/#/issueDate=2026-02-10&serialNumber=99359933
Disclaimer: Curated by HT Syndication....